Lynch syndrome
A New Shield Against Cancer: The Lynch Syndrome Vaccine
For people living with Lynch syndrome, the threat of cancer is a constant shadow. This inherited condition affects about one in 300 people, making them
FDA Expands GSK’s Arexvy Approval to Younger Adults at Elevated RSV Risk
- March 24, 2026
An Excerpt from “A Ribbon for Your Hair”
Telix Pharmaceuticals Advances Brain Cancer Imaging with European Regulatory Submission
VIS-101 Demonstrates Favorable Safety and Early Efficacy in Wet AMD
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Rare Disease
Blood-Based circRNA Marker Shows Promise for Predicting Antidepressant Response
As reported on MedicalXpress, a new study published in Molecular Psychiatry suggests that a specific circular RNA found in blood, known as CDR1as, may help
Prader-Willi Syndrome
Aardvark Pauses Late‑Stage Prader–Willi Trial After Cardiac Signals Emerge
As reported on BioPharmaDive, Aardvark Therapeutics has halted dosing and enrollment in its late‑stage HERO trial for ARD‑101, a first‑in‑class treatment candidate for Prader–Willi syndrome
Breast Cancer
Myth or Truth? Avoid Soy If You Have a Hormone-Positive Cancer
Editor’s Note: Patient Worthy is pleased to bring you this article, originally shared with us by our friend Julie Lanford, The Cancer Dietitian. To see
Breast Cancer
Breaking New Ground: FDA Green-Lights Novel Breast Cancer Treatment Targeting Treatment-Resistant Tumors
The landscape of advanced breast cancer treatment is shifting. Genentech’s filing acceptance of giredestrant, an experimental oral medication, represents a pivotal moment for thousands of
Huntington's disease
Vico Therapeutics Begins Twice‑Yearly Dosing of VO659 in Phase 1/2 Trial for Huntington’s Disease and Spinocerebellar Ataxias
As reported in Business Wire, Vico Therapeutics has initiated patient dosing in an expanded cohort of its Phase 1/2a clinical study evaluating VO659, an antisense
Myelofibrosis
James’ Story: Navigating Life With Myelofibrosis
Editor’s Note: This article was shared with us by our friends at Heal Canada. To see the article in its original format, please click here.
Chronic Lymphocytic Leukemia
FDA Approves Revolutionary Oral Combination Therapy for Chronic Lymphocytic Leukemia, Offering Patients Freedom from Long-Term Treatment
AbbVie has announced a landmark regulatory milestone with the US FDA’s approval of a supplemental new drug application (sNDA) for the combination of Venclexta (venetoclax)
Rare Disease
First Patient Dosed in Phase 3 CLARITY Trial Evaluating Solriamfetol for MDD With Excessive Daytime Sleepiness
As published in Sleep Review Magazine, Axsome Therapeutics has officially begun dosing patients in its Phase 3 CLARITY trial, a study designed to evaluate solriamfetol
Fibrosis
Breaking the Fibrosis Barrier: How Fibrocor Therapeutics Is Revolutionizing Kidney Disease Treatment
Fibrosis, the accumulation of scar tissue in organs, disrupts normal organ function and leads to progressive impairment. Currently, there is no cure, and existing treatments
Diabetes Type 1
A New Chapter in Diabetes Care: Inside-the-Body Technology Breaks Ground
The relationship between people with type 1 diabetes and their medication has always been complicated. For decades, managing the condition has required constant vigilance including
Huntington's disease
Harness Therapeutics Advances First‑in‑Class Huntington’s Disease Candidate HRN001 and Forms Expert Clinical Advisory Board
As reported on PharmaBiz, Harness Therapeutics has selected HRN001 as its lead therapeutic candidate for Huntington’s disease (HD), marking a major milestone for the company
Rare Disease
Life Impact of Pain – Pain Series Part 2 of 3
Click here to see Part 1 of of this 3 part pain series. If you suffer with chronic pain, you not only live with the unrelenting
Obesity
Monthly Obesity Treatment Gets Easier: Lilly’s New Zepbound Pen Simplifies Weight Loss Injections
Patients using Zepbound for weight management now have a simpler option for administering their medication. As reported by PharmaLive.com, Eli Lilly received FDA clearance for
Prostate Cancer
Redefining Cancer Treatment: Podcast Interview with Dr. Charles Link on Sync-T and the Future of Immunotherapy
On this episode of Wait, How Do You Spell That?, host Bree Clare sits down with Dr. Charles Link, a pioneering oncologist whose career has
Bladder cancer
“At 44, I Thought I Was Starting Over” – Kristian’s Bladder Cancer Story
At 44 years old, I was ready to hit the reset button. In March of 2025, my partner and I stepped away from our careers.
Ovarian Cancer
British Columbia Researchers Develop a System to Reduce Ovarian Cancer by 80%
Ovarian cancer is a serious gynecological cancer with no reliable screening test, resulting in limited treatment options and a low number of survivors. Each year
Fibrodysplasia Ossificans Progressiva (FOP)
Breakthrough in Rare Bone Disease: FDA Fast-Tracks Garetosmab for Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the Biologics License Application (BLA) for garetosmab, marking a significant
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
March is Myeloma Action Month ❤️
Multiple myeloma is a type of blood cancer that affects plasma cells in bone marrow, disrupting the body's ability to fight infection and produce healthy blood cells.
Each year, thousands are diagnosed- rates in the US have been rising, with roughly 7-9 new cases per 100,000 people annually. The disease accounts for about 10% of all blood cancers.
Awareness matters. Early detection, recognition, research, and support can change outcomes and save lives!
#MyelomaActionMonth #PatientWorthy #whatnext
Today is American Diabetes Alert Day, a national reminder of the importance of knowing your risk and taking steps toward better health. Diabetes and prediabetes affect millions of people, often without noticeable symptoms, making awareness and early action critical.
This day encourages individuals and families to learn more about risk factors, recognize early warning signs, and start conversations with healthcare providers about screening and prevention. Small steps, such as staying informed, getting tested, and making healthy lifestyle choices, can make a meaningful difference.
American Diabetes Alert Day is meant for everyone, but it is especially important for people who may have higher risk, including those with:
• A family history of diabetes
• Overweight or obesity
• Low physical activity levels
• A history of gestational diabetes
• Certain racial or ethnic backgrounds disproportionately affected by diabetes
#AmericanDiabetesAlertDay #diabetesawareness #KnowYourRisk #DiabetesPrevention #PrediabetesAwareness #HealthAwareness
World Tuberculosis Day is a reminder that TB, an infectious disease that primarily impacts the lungs, is preventable and treatable. Raising awareness helps promote early detection and protect communities around the world. #WorldTuberculosisDay #tuberculosis #PatientWorthy
